Indiana Trust & Investment Management CO Has $207,000 Stake in Colgate-Palmolive (NYSE:CL)

Indiana Trust & Investment Management CO lowered its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 5.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,302 shares of the company’s stock after selling 136 shares during the period. Indiana Trust & Investment Management CO’s holdings in Colgate-Palmolive were worth $207,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of CL. Dark Forest Capital Management LP raised its position in Colgate-Palmolive by 84.4% in the third quarter. Dark Forest Capital Management LP now owns 9,002 shares of the company’s stock worth $640,000 after purchasing an additional 4,121 shares in the last quarter. Federated Hermes Inc. raised its holdings in shares of Colgate-Palmolive by 76.7% in the 3rd quarter. Federated Hermes Inc. now owns 43,703 shares of the company’s stock worth $3,108,000 after buying an additional 18,970 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Colgate-Palmolive by 142.0% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after buying an additional 291 shares during the period. Vinva Investment Management Ltd boosted its stake in Colgate-Palmolive by 9.1% in the 3rd quarter. Vinva Investment Management Ltd now owns 37,534 shares of the company’s stock valued at $2,677,000 after buying an additional 3,117 shares in the last quarter. Finally, Treasurer of the State of North Carolina grew its position in Colgate-Palmolive by 0.4% in the third quarter. Treasurer of the State of North Carolina now owns 371,243 shares of the company’s stock valued at $26,399,000 after acquiring an additional 1,350 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 1.2 %

NYSE:CL traded down $1.18 during trading hours on Friday, reaching $96.99. 11,035,083 shares of the stock were exchanged, compared to its average volume of 4,506,708. The stock has a market cap of $79.57 billion, a PE ratio of 31.07, a PEG ratio of 3.62 and a beta of 0.39. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $99.08. The firm has a 50 day moving average of $93.45 and a 200 day moving average of $87.30. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same quarter in the prior year, the company posted $0.73 earnings per share. The firm’s revenue was up 6.2% on a year-over-year basis. On average, equities analysts expect that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.06%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Royal Bank of Canada boosted their target price on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research note on Monday, April 29th. BNP Paribas started coverage on shares of Colgate-Palmolive in a research note on Monday. They set an “outperform” rating and a $109.00 price objective on the stock. Wells Fargo & Company lifted their target price on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a research note on Monday, April 29th. Bank of America increased their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, April 29th. Finally, Barclays lifted their price objective on Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 30th. Three analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $93.83.

Check Out Our Latest Analysis on Colgate-Palmolive

Insider Buying and Selling

In other news, insider Sally Massey sold 12,226 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the transaction, the insider now owns 3,181 shares in the company, valued at $297,328.07. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.